ARCIW Archimedes Tech SPAC Partners III Co. - Warrant
NASDAQ · View on SEC EDGAR ↗ close Oct 1, 2026 10-K/10-Q Aug 13, 2026ARCIW Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
ARCIW Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ARCIW | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | -0.4 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ARCIW | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 9.5 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
We don't have SEC filings for this ticker yet.
Income Statement
| Metric | Trend | Q2 2026 |
|---|---|---|
| SG&A Expense | $200.1K | |
| Operating Income | $-200.1K | |
| Interest Income | $2M | |
| Other Non-op | $2M | |
| Net Income | $2M | |
| EBITDA | $-200.1K |
Balance Sheet
| Metric | Trend | Q2 2026 |
|---|---|---|
| Cash & Equivalents | $1M | |
| Prepaid Expense | $168.0K | |
| Current Assets | $1M | |
| Total Assets | $281M | |
| Accrued Liabilities | $36.8K | |
| Current Liabilities | $124.0K | |
| Total Liabilities | $10M | |
| Common Stock | $766 | |
| Retained Earnings | $-9M | |
| Stockholders' Equity | $-9M | |
| Liabilities + Equity | $281M | |
| Shares Outstanding | 7,662,000 |
Cash Flow
| Metric | Trend | Q2 2026 |
|---|---|---|
| Operating Cash Flow | $-100.3K | |
| Investing Cash Flow | $0 | |
| Financing Cash Flow | $0 |
Profitability
| Metric | Trend | Q2 2026 |
|---|---|---|
| ROA | 1.6% | |
| ROE | -53.6% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 |
|---|---|---|
| Current Ratio | 9.5 | |
| Quick Ratio | 8.1 |
Per Share
| Metric | Trend | Q2 2026 |
|---|---|---|
| Book Value / Share | $-1.11 | |
| Cash / Share | $0.13 |
Valuation (TTM)
| Metric | Trend | Q2 2026 |
|---|---|---|
| Market Cap | $6M | |
| P/B | -0.7 |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Not enough fundamentals data to build this statement yet.
Not enough fundamentals data to build this statement yet.
Not enough fundamentals data to build this statement yet.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.